One study in 2019 demonstrated that plasma levels of kisspeptin were severely reduced in T2DM male patients (8.34 ng/ml) compared with the healthy control group (16.26 ng/ml). This evidence concerns the gene KISS1 and type 2 diabetes mellitus.